| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
Laboratory of Molecular Immunology, Department of Neurology, Brigham and Women’s Hospital, Boston, MA 02115;
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA 02115;
Harvard Medical School, Boston, MA 02115
Multiple sclerosis (MS) is an inflammatory disease of the myelinated central nervous system that is postulated to be induced by myelin-reactive CD4 T cells. T cell activation requires an antigen-specific signal through the TCR and a costimulatory signal, which can be mediated by B7–1 or B7–2 engagement of CD28. To directly examine the activation state of myelin-reactive T cells in MS, the costimulation requirements necessary to activate myelin basic protein (MBP) or tetanus toxoid (TT)-reactive CD4 T cells were compared between normal controls and MS patients. Peripheral blood T cells were stimulated with Chinese hamster ovary (CHO) cells transfected either with DRB1*1501/DRA0101 chains (t-DR2) alone, or in combination with, B7–1 or B7–2. In the absence of costimulation, T cells from normal subjects stimulated with the recall antigen TT p830–843 were induced to expand and proliferate, but stimulation with MBP p85–99 did not have this effect. In marked contrast, T cells from patients with MS stimulated with MBP p85–99 in the absence of B7–1 or B7–2 signals expanded and proliferated. Thus, MBP-reactive CD4 T cells in patients with MS are costimulation independent and have been previously activated in vivo. These experiments provide further direct evidence for a role of activated MBP-specific CD4 T cells in the pathogenesis of MS.
This article has been cited by other articles:
|
|
 |
|
  D. T. Okuda, R. Srinivasan, J. R. Oksenberg, D. S. Goodin, S. E. Baranzini, A. Beheshtian, E. Waubant, S. S. Zamvil, D. Leppert, P. Qualley, et al. Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures Brain, January 1, 2009; 132(1): 250 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Miyazaki, K Iwabuchi, S Kikuchi, T Fukazawa, M Niino, M Hirotani, H Sasaki, and K Onoe Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis Multiple Sclerosis, September 1, 2008; 14(8): 1044 - 1055. [Abstract] [PDF]
|
|
|
|
 |
|
 W. Elyaman, P. Kivisakk, J. Reddy, T. Chitnis, K. Raddassi, J. Imitola, E. Bradshaw, V. K. Kuchroo, H. Yagita, M. H. Sayegh, et al. Distinct Functions of Autoreactive Memory and Effector CD4+ T Cells in Experimental Autoimmune Encephalomyelitis Am. J. Pathol., August 1, 2008; 173(2): 411 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Maier, D. E. Anderson, P. L. De Jager, L. S. Wicker, and D. A. Hafler Allelic variant in CTLA4 alters T cell phosphorylation patterns PNAS, November 20, 2007; 104(47): 18607 - 18612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-Z. Liu, L.-B. Fang, P. Hjelmstrom, and X.-G. Gao Increased CD8+ central memory T cells in patients with multiple sclerosis Multiple Sclerosis, March 1, 2007; 13(2): 149 - 155. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Wang, R. Allie, K. Conant, N. Haughey, J. Turchan-Chelowo, K. Hahn, A. Rosen, J. Steiner, S. Keswani, M. Jones, et al. Granzyme B mediates neurotoxicity through a G-protein-coupled receptor FASEB J, June 1, 2006; 20(8): 1209 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Frohman, M. K. Racke, and C. S. Raine Multiple sclerosis--the plaque and its pathogenesis. N. Engl. J. Med., March 2, 2006; 354(9): 942 - 955. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yang, N. A. Danke, D. Berger, S. Reichstetter, H. Reijonen, C. Greenbaum, C. Pihoker, E. A. James, and W. W. Kwok Islet-Specific Glucose-6-Phosphatase Catalytic Subunit-Related Protein-Reactive CD4+ T Cells in Human Subjects. J. Immunol., March 1, 2006; 176(5): 2781 - 2789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Frohman, M. Filippi, O. Stuve, S. G. Waxman, J. Corboy, J. T. Phillips, C. Lucchinetti, J. Wilken, N. Karandikar, B. Hemmer, et al. Characterizing the Mechanisms of Progression in Multiple Sclerosis: Evidence and New Hypotheses for Future Directions Arch Neurol, September 1, 2005; 62(9): 1345 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Rus, C. A. Pardo, L. Hu, E. Darrah, C. Cudrici, T. Niculescu, F. Niculescu, K. M. Mullen, R. Allie, L. Guo, et al. The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain PNAS, August 2, 2005; 102(31): 11094 - 11099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Croxford, J. K. Olson, H. A. Anger, and S. D. Miller Initiation and Exacerbation of Autoimmune Demyelination of the Central Nervous System via Virus-Induced Molecular Mimicry: Implications for the Pathogenesis of Multiple Sclerosis J. Virol., July 1, 2005; 79(13): 8581 - 8590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Beeton, M. W. Pennington, H. Wulff, S. Singh, D. Nugent, G. Crossley, I. Khaytin, P. A. Calabresi, C.-Y. Chen, G. A. Gutman, et al. Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases Mol. Pharmacol., April 1, 2005; 67(4): 1369 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Croxford, H. A. Anger, and S. D. Miller Viral Delivery of an Epitope from Haemophilus influenzae Induces Central Nervous System Autoimmune Disease by Molecular Mimicry J. Immunol., January 15, 2005; 174(2): 907 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. K. Singh and J. Z. Zhang Differential Activation of ERK, p38, and JNK Required for Th1 and Th2 Deviation in Myelin-Reactive T Cells Induced by Altered Peptide Ligand J. Immunol., December 15, 2004; 173(12): 7299 - 7307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hohlfeld and H. Wekerle Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines PNAS, October 5, 2004; 101(suppl_2): 14599 - 14606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takahashi, T. Aranami, M. Endoh, S. Miyake, and T. Yamamura The regulatory role of natural killer cells in multiple sclerosis Brain, September 1, 2004; 127(9): 1917 - 1927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Baecher-Allan and D. A. Hafler Suppressor T Cells in Human Diseases J. Exp. Med., August 2, 2004; 200(3): 273 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Mycko, H. Waldner, D. E. Anderson, K. D. Bourcier, K. W. Wucherpfennig, V. K. Kuchroo, and D. A. Hafler Cross-Reactive TCR Responses to Self Antigens Presented by Different MHC Class II Molecules J. Immunol., August 1, 2004; 173(3): 1689 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vennekamp, H. Wulff, C. Beeton, P. A. Calabresi, S. Grissmer, W. Hansel, and K. G. Chandy Kv1.3-Blocking 5-Phenylalkoxypsoralens: A New Class of Immunomodulators Mol. Pharmacol., June 1, 2004; 65(6): 1364 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Viglietta, C. Baecher-Allan, H. L. Weiner, and D. A. Hafler Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis J. Exp. Med., April 5, 2004; 199(7): 971 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Dromey, S. M. Weenink, G. H. Peters, J. Endl, P. J. Tighe, I. Todd, and M. R. Christie Mapping of Epitopes for Autoantibodies to the Type 1 Diabetes Autoantigen IA-2 by Peptide Phage Display and Molecular Modeling: Overlap of Antibody and T Cell Determinants J. Immunol., April 1, 2004; 172(7): 4084 - 4090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bielekova, M.-H. Sung, N. Kadom, R. Simon, H. McFarland, and R. Martin Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+ T Cells in Multiple Sclerosis J. Immunol., March 15, 2004; 172(6): 3893 - 3904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas Theiler's Virus Infection: a Model for Multiple Sclerosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Lutton, R. Winston, and T. C. Rodman Multiple Sclerosis: Etiological Mechanisms and Future Directions Experimental Biology and Medicine, January 1, 2004; 229(1): 12 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Beeton, H. Wulff, S. Singh, S. Botsko, G. Crossley, G. A. Gutman, M. D. Cahalan, M. Pennington, and K. G. Chandy A Novel Fluorescent Toxin to Detect and Investigate Kv1.3 Channel Up-regulation in Chronically Activated T Lymphocytes J. Biol. Chem., March 7, 2003; 278(11): 9928 - 9937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Buckle, P. Hollsberg, and D. A. Hafler Activated CD8+ T cells in secondary progressive MS secrete lymphotoxin Neurology, February 25, 2003; 60(4): 702 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bar-Or, E. M. L Oliveira, D. E. Anderson, J. I. Krieger, M. Duddy, K. C. O'Connor, and D. A. Hafler Immunological Memory: Contribution of Memory B Cells Expressing Costimulatory Molecules in the Resting State J. Immunol., November 15, 2001; 167(10): 5669 - 5677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yi, M. McNerney, and S. K. Datta Regulatory Defects in Cbl and Mitogen-Activated Protein Kinase (Extracellular Signal-Related Kinase) Pathways Cause Persistent Hyperexpression of CD40 Ligand in Human Lupus T Cells J. Immunol., December 1, 2000; 165(11): 6627 - 6634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Krogsgaard, K. W. Wucherpfennig, B. Canella, B. E. Hansen, A. Svejgaard, J. Pyrdol, H. Ditzel, C. Raine, J. Engberg, and L. Fugger Visualization of Myelin Basic Protein (Mbp) T Cell Epitopes in Multiple Sclerosis Lesions Using a Monoclonal Antibody Specific for the Human Histocompatibility Leukocyte Antigen (Hla)-Dr2-Mbp 85-99 Complex J. Exp. Med., April 17, 2000; 191(8): 1395 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. K. Singh, Y. C. Q. Zang, A. Shrivastava, J. Hong, G. T. Wang, S. Li, M. V. Tejada-Simon, M. Kozovska, V. M. Rivera, and J. Z. Zhang Th1 and Th2 Deviation of Myelin-Autoreactive T Cells by Altered Peptide Ligands Is Associated with Reciprocal Regulation of Lck, Fyn, and ZAP-70 J. Immunol., December 15, 1999; 163(12): 6393 - 6402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Smith, J. Pyrdol, L. Gauthier, D. C. Wiley, and K. W. Wucherpfennig Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein J. Exp. Med., October 19, 1998; 188(8): 1511 - 1520. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
